Provectus Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc.

PVCT 0.0650

+0.2%

Nov 18 12:36 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: jm2i123 who wrote (11913)	5/12/2013 12:24:08 PM
From: NTTG	2 Recommendations Read Replies (1) of 13111

Let me think.... How about access to potential partners and business development opportunities, everyone understands that. Oh wait, PVCT is going to China, France, India to scrape up partners, no one in US markets wants to partner with them? How about access to potential investigators and study sites for a planned PIII trial, MM patients are in high demand for clinical trials. The more sites you have the faster you can recruit patients Yea, since none of those goals apply to PVCT why would they want to go? How much is air fare to China, France,India....Chicago (got my round trip TYS - ORD tickets to ASCO for < $400 a week ago).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next